Summary Judgment Partially Granted In Pharmaceutical Securities Fraud Dispute

(September 8, 2023, 2:24 PM EDT) -- CAMDEN, N.J. — A federal judge in New Jersey granted some aspects of the defendants’ motions for summary judgment in a putative class complaint wherein a pension fund claimed that a pharmaceutical company artificially inflated its stock value to stave off a buyout, with the judge finding that the pension fund had failed to establish falsity and scienter for some of the company’s allegedly misleading statements....

Attached Documents

Related Sections